CD320 and cancer: NO-Cbl is a vitamin B12 based, nitric oxide donor, that functions as a biological “Trojan Horse” targeting cancer cells via vitamin B12 receptor (Transcobalamin II receptor, TCIIR)[31], [32] mediated uptake[29] similar to clinical studies that target TCIIR in the detection of cancer[33], [34].